Debbane Raymond's Form 4 filing
Lexicon Pharmaceuticals, Inc. (LXRX) · filed Aug 1, 2022
- Accession no.
- 0000899243-22-027157
- Filed
- Aug 1, 2022, 4:15 PM ET
- Trade date
- Aug 1, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.46M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Debbane RaymondCIK 0001053890 | Director, 10% Owner |
| Ulys, L.L.C.CIK 0001340098 | Director, 10% Owner |
| Invus US Partners LLCCIK 0001839806 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | Common Stock | PPurchaseAcquired | +982,600 | $2.50 | +$2,456,500 | 5,303,814 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.